FISHERMAN JASON S 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Jun 8, 2018
Insider Transaction Report
Form 4
FISHERMAN JASON S
Director
Transactions
- Exercise/Conversion
Employee Stock Option
2018-06-06−20,000→ 0 totalExercise: $1.05Exp: 2018-12-15→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2018-06-06$1.05/sh+20,000$21,000→ 70,000 total
Holdings
- 1,500(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]This option was granted on December 15, 2008 and vested over a four year period with 25% of the shares vesting on the first anniversary of the grant date and an additional 6.25% vesting at the end of each three-month period thereafter.